Browse All

Current Filters

CLEAR FILTER x

TITLE

Attention to Sex as a Biological Variable in Phase III Neurological Trials Before and After the 2017 NIH Amendment: a Systematic Review in MS

Author:Balan, Ayushi   Bove, Riley   Sormani, Maria Pia   Houtchens, Maria   

Session Name:P4: Multiple Sclerosis: Special Populations  

Topic:Multiple Sclerosis  

Program Number:P4.001  

Author Institution:UCSF, San Francisco, CA  University of California, San Francisco, Berkeley, CA  University of Genoa, Genoa, Italy  Brigham and Women's Hospital , Boston, MA  

The Safety Profile of Fenebrutinib in Patients with Multiple Sclerosis Is Consistent with Those in Previously Studied Autoimmune Indications

Author:Oh, Jiwon   Raievska, Anastasiia   Sierzega, Malgorzata   Cerqueira, João   Riley, Claire S.   Caunt, Maresa   Ratchford, John N.   Goodyear, Alexandra   Vanevski, Konstantina   Sormani, Maria Pia   Giovannoni, Gavin   

Session Name:P9: Multiple Sclerosis: Clinical Trials and Therapeutics (including Safety) 2  

Topic:Multiple Sclerosis  

Program Number:P9.012  

Author Institution:St. Michael's Hospital, University of Toronto, Toronto, ON, Canada  F. Hoffmann-La Roche Ltd, Basel, Switzerland  University of Minho, Braga, Portugal  Columbia University Medical Center, New York, NY  Genentech Inc., South San Francisco, CA  University of Genoa, Genoa, Italy  Blizard University, Queen Mary University of London, London, United Kingdom